1. Home
  2. MLR vs RIGL Comparison

MLR vs RIGL Comparison

Compare MLR & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLR
  • RIGL
  • Stock Information
  • Founded
  • MLR 1990
  • RIGL 1996
  • Country
  • MLR United States
  • RIGL United States
  • Employees
  • MLR N/A
  • RIGL N/A
  • Industry
  • MLR Construction/Ag Equipment/Trucks
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLR Consumer Discretionary
  • RIGL Health Care
  • Exchange
  • MLR Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • MLR 468.2M
  • RIGL 537.6M
  • IPO Year
  • MLR 1994
  • RIGL 2000
  • Fundamental
  • Price
  • MLR $36.00
  • RIGL $42.19
  • Analyst Decision
  • MLR Buy
  • RIGL Buy
  • Analyst Count
  • MLR 2
  • RIGL 6
  • Target Price
  • MLR $55.00
  • RIGL $39.83
  • AVG Volume (30 Days)
  • MLR 67.6K
  • RIGL 667.2K
  • Earning Date
  • MLR 11-05-2025
  • RIGL 11-04-2025
  • Dividend Yield
  • MLR 2.23%
  • RIGL N/A
  • EPS Growth
  • MLR N/A
  • RIGL 2698.26
  • EPS
  • MLR 2.58
  • RIGL 6.20
  • Revenue
  • MLR $840,260,000.00
  • RIGL $282,076,000.00
  • Revenue This Year
  • MLR N/A
  • RIGL $59.93
  • Revenue Next Year
  • MLR $26.85
  • RIGL N/A
  • P/E Ratio
  • MLR $13.92
  • RIGL $6.86
  • Revenue Growth
  • MLR N/A
  • RIGL 79.13
  • 52 Week Low
  • MLR $33.81
  • RIGL $14.63
  • 52 Week High
  • MLR $76.25
  • RIGL $43.72
  • Technical
  • Relative Strength Index (RSI)
  • MLR 31.03
  • RIGL 71.79
  • Support Level
  • MLR $37.35
  • RIGL $34.00
  • Resistance Level
  • MLR $39.00
  • RIGL $39.56
  • Average True Range (ATR)
  • MLR 1.47
  • RIGL 2.38
  • MACD
  • MLR -0.35
  • RIGL 1.16
  • Stochastic Oscillator
  • MLR 0.69
  • RIGL 99.11

About MLR Miller Industries Inc.

Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: